Ibritumomab tiuxetan
₹500.00
Ibritumomab tiuxetan is a medication used in the treatment of certain types of non-Hodgkin's lymphoma, a type of cancer that affects the lymphatic system. Let's break down what Ibritumomab tiuxetan is, how it works, and why it's used in simple terms.
Firstly, Ibritumomab tiuxetan is a type of targeted therapy called radioimmunotherapy. This means that it combines the properties of a monoclonal antibody with a radioactive substance to specifically target and destroy cancer cells.
Imagine your body's immune system as an army that defends against invaders like bacteria and viruses. Sometimes, cancer cells can disguise themselves and evade detection by the immune system. This is where Ibritumomab tiuxetan comes in.
Ibritumomab tiuxetan is like a guided missile that seeks out and attaches to a protein called CD20, which is found on the surface of certain white blood cells called B cells. In non-Hodgkin's lymphoma, these B cells become cancerous and multiply uncontrollably.
Once attached to the CD20 protein, Ibritumomab tiuxetan delivers a dose of radiation directly to the cancer cells. This radiation damages the DNA inside the cancer cells, preventing them from dividing and eventually causing them to die.
One of the advantages of Ibritumomab tiuxetan is that it can target cancer cells while sparing healthy cells as much as possible. This can result in fewer side effects compared to traditional chemotherapy, which can affect both cancerous and healthy cells.
Ibritumomab tiuxetan is usually given as an infusion into a vein, typically in a hospital or clinic setting. The dosage and frequency of treatment depend on factors like the type and stage of non-Hodgkin's lymphoma, as well as the individual's overall health.
Like any medication, Ibritumomab tiuxetan isn't without risks. Some common side effects include low blood cell counts, fatigue, nausea, and vomiting. These side effects are usually temporary and can often be managed with proper medical care.
In summary, Ibritumomab tiuxetan is a targeted therapy used in the treatment of non-Hodgkin's lymphoma by specifically targeting and destroying cancer cells while sparing healthy cells as much as possible. While it can be effective in treating this type of cancer, it's essential for patients to discuss potential benefits and risks with their doctors before starting treatment. Ibritumomab tiuxetan offers hope for individuals battling non-Hodgkin's lymphoma and provides another option in the fight against cancer.
Have any queries, book a consultation with our Oncology Clinical Specialist
Quantity
How does this medicine work
Imagine your body is a city, and your cells are the residents. Some cells, called B cells, start growing out of control and causing trouble like a gang of troublemakers. These B cells are the ones responsible for non-Hodgkin's lymphoma.
Ibritumomab tiuxetan is like a smart missile designed to target these troublemaking B cells. It homes in on a specific protein called CD20, which is like a marker found on the surface of these B cells.
Once it finds its target, Ibritumomab tiuxetan delivers a powerful punch of radiation directly to these cancerous B cells. This radiation damages their DNA, essentially crippling them and stopping them from multiplying further.
By specifically targeting the cancer cells, Ibritumomab tiuxetan helps to shrink the tumor and slow down the progression of the disease. It's like taking out the ringleaders of a gang, which helps restore peace and order to the city, or in this case, the body.
Overall, Ibritumomab tiuxetan is a targeted therapy that seeks out and destroys cancer cells while sparing healthy cells as much as possible. It's like a precision strike against cancer, giving patients a chance to fight back and reclaim their health.
Have any queries, book a consultation with our Oncology Clinical Specialist
What is useful for?
Ibritumomab tiuxetan is useful for treating certain types of non-Hodgkin's lymphoma, a type of cancer that affects the lymphatic system. It specifically targets and destroys cancerous B cells, helping to shrink tumors and slow down the progression of the disease. This medication provides a targeted approach to treating non-Hodgkin's lymphoma, offering hope to patients battling this type of cancer.
Visit our Research Division Doctors in Online Consults for more details.
What if you miss the dose?
If you miss a dose of Ibritumomab tiuxetan, it's important to let your healthcare provider know as soon as possible. They will advise you on the best course of action.
Missing a dose can affect the effectiveness of the treatment, so it's essential to follow your doctor's instructions carefully. They may schedule another dose for you or adjust your treatment plan accordingly.
It's crucial not to try to make up for the missed dose by taking extra medication on your own. Taking too much can increase the risk of side effects and complications.
If you have any concerns or questions about missed doses, don't hesitate to reach out to your healthcare provider for guidance. They're there to help you navigate your treatment and ensure the best possible outcomes.
Please book a consultation with our Oncology Clinical Specialist to know more about what happens if you miss the dose.
Will there be Side Effects
Yes, like all medications, Ibritumomab tiuxetan can cause side effects. These can vary from person to person, but some common side effects may include:
1. **Fatigue:** Feeling tired or lacking energy.
2. **Nausea and Vomiting:** Feeling sick to your stomach or throwing up.
3. **Low Blood Cell Counts:** This can lead to an increased risk of infections, bruising or bleeding easily, and feeling weak or dizzy.
4. **Fever:** A higher than normal body temperature.
5. **Pain or Swelling at the Injection Site:** Where the medication was administered.
It's important to remember that not everyone will experience side effects, and they may vary in severity. Your healthcare provider will monitor you closely during treatment and can help manage any side effects you may experience.
If you notice any side effects or have concerns about your treatment, be sure to talk to your healthcare provider. They can provide guidance and support to help you through your treatment journey.
Have any queries, book a consultation with our Oncology Clinical Specialist
Tell us if you are taking other medicines like:-
If you're taking other medicines along with Ibritumomab tiuxetan, it's important to let our doctor know. This is like giving them a full picture of your health so they can make sure all your medicines work well together and are safe for you to take.
Some medicines might interact with Ibritumomab tiuxetan, meaning they could affect how well it works or cause unwanted side effects. By telling our doctor about all the medicines you're taking, including prescription drugs, over-the-counter medications, and even herbal supplements, they can check for any potential interactions and make sure it's safe for you to take them together.
So, always keep our doctor informed about all the medicines you're taking, and they'll help you stay safe and healthy during your treatment with Ibritumomab tiuxetan.
Have any queries, book a consultation with our Oncology Clinical Specialist
Safety Advice : Pregnancy, Liver or Kidney Damaged
Here's some simple safety advice regarding pregnancy, liver, or kidney issues when using Ibritumomab tiuxetan:
1. **Pregnancy:** If you're pregnant or planning to become pregnant, it's important to let our doctor know before starting Ibritumomab tiuxetan. This medication can harm an unborn baby, so it's essential to use effective contraception during treatment and avoid getting pregnant. If you become pregnant while on Ibritumomab tiuxetan, inform our doctor immediately.
2. **Liver or Kidney Problems:** If you have liver or kidney issues, it's essential to discuss this with your doctor before starting Ibritumomab tiuxetan. These organs help process medications in your body, and if they're not working well, it could affect how Ibritumomab tiuxetan works or increase the risk of side effects. Your doctor may need to adjust your dosage or monitor you more closely during treatment.
By following these simple safety guidelines, you can help ensure that Ibritumomab tiuxetan is used safely and effectively for your treatment.
Have any queries, book a consultation with our Oncology Clinical Specialist
Pi Cancer Care
Copyright 2024 Reserved - Pi Cancer Care Clinic
77997 20123
Hyderabad
Home
Terms & Conditions
Privacy policy
Refund Policy